Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cybin Inc
(NY:
CYBN
)
10.15
+0.03 (+0.30%)
Official Closing Price
Updated: 6:30 PM EST, Nov 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
57,600
Open
9.960
Bid (Size)
9.800 (1)
Ask (Size)
10.39 (9)
Prev. Close
10.12
Today's Range
9.940 - 10.18
52wk Range
6.500 - 22.31
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) CEO to Present Advancements in Mental Health Treatment at Milken Institute Summit
October 31, 2024
Via
Investor Brand Network
Cybin to Participate at the 2024 Milken Institute Future of Health Summit
October 31, 2024
From
Cybin Inc.
Via
Business Wire
Performance
YTD
-33.22%
-33.22%
1 Month
+13.28%
+13.28%
3 Month
+0.79%
+0.79%
6 Month
-27.42%
-27.42%
1 Year
-53.14%
-53.14%
More News
Read More
BioMedNewsBreaks — Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Granted Patent for Lead Candidates in CYB005 Program
October 24, 2024
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
CYBN Stock Earnings: Cybin Beats EPS for Q1 2024
August 09, 2024
Via
InvestorPlace
Cybin Announces Grant of First U.S. Composition of Matter Patent in Support of its CYB005 Phenethylamines Program
October 24, 2024
From
Cybin Inc.
Via
Business Wire
EXCLUSIVE: Neuropsychiatry-Focused Cybin Secures First US Composition of Matter Patent For Preclinical CYB005 Phenethylamines Program
October 24, 2024
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) CEO to Participate in Upcoming Water Tower Research Fireside Chat
October 03, 2024
Via
Investor Brand Network
Exposures
Product Safety
Cybin to Participate in Water Tower Research Fireside Chat on October 8, 2024
October 03, 2024
From
Cybin Inc.
Via
Business Wire
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Strengthens Its Clinical Development Team
October 01, 2024
Via
Investor Brand Network
Cybin Expands Clinical Team to Support CYB003 Phase 3 Program
October 01, 2024
From
Cybin Inc.
Via
Business Wire
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Chief Medical Officer to Participate in a Panel Discussion at Upcoming Summit
September 24, 2024
Via
Investor Brand Network
Cybin to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit
September 24, 2024
From
Cybin Inc.
Via
Business Wire
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Reports on Status of Key Clinical Milestones
September 20, 2024
Via
Investor Brand Network
Cybin Provides Corporate Update on Upcoming Clinical Milestones
September 19, 2024
From
Cybin Inc.
Via
Business Wire
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Completes 38-for-1 Share Consolidation
September 19, 2024
Via
Investor Brand Network
Cybin Announces Completion of Previously Announced Share Consolidation
September 19, 2024
From
Cybin Inc.
Via
Business Wire
Leadership Shake-Ups In Cannabis And Psychedelics: Maryland's Cannabis Chief Resigns, Costly Legal Battle In MA Drags On & More
September 06, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) CEO to Participate at the H.C. Wainwright 26th Annual Global Investment Conference
September 04, 2024
Via
Investor Brand Network
Cybin to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
September 04, 2024
From
Cybin Inc.
Via
Business Wire
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Reports on Annual and Special Meeting of Shareholders, Share Consolidation
August 28, 2024
Via
Investor Brand Network
Cybin Announces Results of Annual and Special Meeting of Shareholders and Share Consolidation
August 27, 2024
From
Cybin Inc.
Via
Business Wire
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Holds Initial Breakthrough Therapy Meeting with FDA, Plans for CYB003 Phase 3 Trial
August 13, 2024
Via
Investor Brand Network
Exposures
Product Safety
Cybin Announces Completion of FDA Type B Initial Breakthrough Therapy Meeting and Plans for CYB003 Phase 3 Program in Major Depressive Disorder
August 13, 2024
From
Cybin Inc.
Via
Business Wire
BioMedNewsBreaks — Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Releases Q1 2025 Financial Results, Business Highlights
August 08, 2024
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Cybin Reports First Quarter Fiscal Year 2025 Financial Results and Recent Business Highlights
August 08, 2024
From
Cybin Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
